Document is current
Any future updates will be listed below
-
Authors
Goyal, Shiwali
Tanigawa, Yosuke
Zhang, Weihua
Chai, Jin-Fang
Almeida, Marcio
Sim, Xueling
Lerner, Megan
Chainakul, Juliane
Ramiu, Jonathan Garcia
Seraphin, Chanel
Apple, Blair
Vaughan, April
Muniu, James
Peralta, Juan
Lehman, Donna M.
Ralhan, Sarju
Wander, Gurpreet S.
Singh, Jai Rup
Mehra, Narinder K.
Sidorov, Evgeny
Peyton, Marvin D.
Blackett, Piers R.
Curran, Joanne E.
Tai, E. Shyong
van Dam, Rob
Cheng, Ching-Yu
Duggirala, Ravindranath
Blangero, John
Chambers, John C.
Sabanayagam, Charumathi
Kooner, Jaspal S.
Rivas, Manuel A.
Aston, Christopher E.
Sanghera, Dharambir K.
-
Funding
Funding for this research was provided by:
national institutes of health (R01DK082766)
national institute of diabetes and digestive and kidney diseases (R01DK118427)
national human genome research institute (NOT-HG-11-009)
- License Information
-
More Information
Article History
Received: 29 July 2021
Accepted: 25 August 2021
First Online: 21 September 2021
Declarations
:
: All AIDHS/SDS protocols and consent documents were reviewed and approved by the University of Oklahoma Health Science Center’s Institutional Review Board (IRB) as well as the Human Subject Protection (Ethics) committees at the participating hospitals and institutes in India. The LOLIPOP study is approved by the National Research Ethics Service (07/H0712/150) and all participants gave written informed consent at enrollment. The SAFHS and SAFDGS study-specific protocols have been approved by the Institutional Review Boards of the University of Texas Health San Antonio and the University of Texas Rio Grande Valley, and informed consent was obtained from all SAFHS and SAFDGS participants, respectively. Ethics approval for the UKBB was obtained from the North West Centre for Research Ethics Committee (11/NW/0382). All the participants of UKBB provided written informed consent.
: NA.
: We declare that no conflict of interest could be perceived as prejudicing the impartiality of the research reported.
